Cordium Pharmaceuticals Pvt Ltd is a trusted global exporter of Sunitinib Malate Capsules 50 mg from India, delivering high-quality pharmaceutical formulations with reliable and fast international shipping to major global markets including the United States, United Kingdom, Germany, Netherlands, South Africa, United Arab Emirates, and Brazil.
Sunitinib Malate is a well-established anticancer tyrosine kinase inhibitor (TKI) widely used in targeted cancer therapy under medical supervision.
💊 PRODUCT OVERVIEW: SUNITINIB MALATE CAPSULES 50 mg
Sunitinib Malate Capsules 50 mg are prescribed for the treatment of certain types of cancers by inhibiting tumor growth and reducing blood supply to cancer cells.
🧪 USES / INDICATIONS
Sunitinib Malate is commonly used for:
Renal Cell Carcinoma (RCC)
Gastrointestinal Stromal Tumor (GIST)
Pancreatic Neuroendocrine Tumors (pNET)
Other advanced or metastatic cancers (as prescribed by oncologists)
💊 DOSAGE INFORMATION
Standard dose: 50 mg once daily
Typical cycle: 4 weeks ON treatment followed by 2 weeks OFF
Dosage may vary based on:
Patient condition
Body response
Oncologist recommendation
⚠️ Must be taken strictly under medical supervision.
⚠️ SIDE EFFECTS
Possible side effects may include:
Fatigue and weakness
Nausea, vomiting, or diarrhea
Loss of appetite
High blood pressure
Skin discoloration or hand-foot syndrome
Mouth sores
Liver function changes
Reduced blood cell counts
🚨 Serious side effects require immediate medical attention.
🌐 GLOBAL EXPORT & DELIVERY NETWORK
Cordium Pharmaceuticals Pvt Ltd ensures safe, compliant, and timely export services with efficient logistics support to:
🇺🇸 United States
🇬🇧 United Kingdom
🇩🇪 Germany
🇳🇱 Netherlands
🇿🇦 South Africa
🇦🇪 United Arab Emirates
🇧🇷 Brazil
We focus on quality assurance, regulatory compliance, and secure international pharmaceutical supply chains.
📞 CONTACT FOR EXPORT INQUIRIES
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Sunitinib Malate is a well-established anticancer tyrosine kinase inhibitor (TKI) widely used in targeted cancer therapy under medical supervision.
💊 PRODUCT OVERVIEW: SUNITINIB MALATE CAPSULES 50 mg
Sunitinib Malate Capsules 50 mg are prescribed for the treatment of certain types of cancers by inhibiting tumor growth and reducing blood supply to cancer cells.
🧪 USES / INDICATIONS
Sunitinib Malate is commonly used for:
Renal Cell Carcinoma (RCC)
Gastrointestinal Stromal Tumor (GIST)
Pancreatic Neuroendocrine Tumors (pNET)
Other advanced or metastatic cancers (as prescribed by oncologists)
💊 DOSAGE INFORMATION
Standard dose: 50 mg once daily
Typical cycle: 4 weeks ON treatment followed by 2 weeks OFF
Dosage may vary based on:
Patient condition
Body response
Oncologist recommendation
⚠️ Must be taken strictly under medical supervision.
⚠️ SIDE EFFECTS
Possible side effects may include:
Fatigue and weakness
Nausea, vomiting, or diarrhea
Loss of appetite
High blood pressure
Skin discoloration or hand-foot syndrome
Mouth sores
Liver function changes
Reduced blood cell counts
🚨 Serious side effects require immediate medical attention.
🌐 GLOBAL EXPORT & DELIVERY NETWORK
Cordium Pharmaceuticals Pvt Ltd ensures safe, compliant, and timely export services with efficient logistics support to:
🇺🇸 United States
🇬🇧 United Kingdom
🇩🇪 Germany
🇳🇱 Netherlands
🇿🇦 South Africa
🇦🇪 United Arab Emirates
🇧🇷 Brazil
We focus on quality assurance, regulatory compliance, and secure international pharmaceutical supply chains.
📞 CONTACT FOR EXPORT INQUIRIES
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Keywords
